Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Days Sales Outstanding : 11,515.75 (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Freeline Therapeutics Holdings Days Sales Outstanding?

Freeline Therapeutics Holdings's average Accounts Receivable for the three months ended in Sep. 2023 was $0.63 Mil. Freeline Therapeutics Holdings's Revenue for the three months ended in Sep. 2023 was $0.01 Mil. Hence, Freeline Therapeutics Holdings's Days Sales Outstanding for the three months ended in Sep. 2023 was 11,515.75.

The historical rank and industry rank for Freeline Therapeutics Holdings's Days Sales Outstanding or its related term are showing as below:

FRLN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 0 Med: 0 Max: 370.09
Current: 370.09

During the past 5 years, Freeline Therapeutics Holdings's highest Days Sales Outstanding was 370.09. The lowest was 0.00. And the median was 0.00.

FRLN's Days Sales Outstanding is not ranked
in the Biotechnology industry.
Industry Median: 72.43 vs FRLN: 370.09

Freeline Therapeutics Holdings's Days Sales Outstanding increased from Sep. 2022 (0.00) to Sep. 2023 (11,515.75).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Freeline Therapeutics Holdings Days Sales Outstanding Historical Data

The historical data trend for Freeline Therapeutics Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Freeline Therapeutics Holdings Days Sales Outstanding Chart

Freeline Therapeutics Holdings Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Days Sales Outstanding

Freeline Therapeutics Holdings Quarterly Data
	Dec18	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Days Sales Outstanding	Get a 7-Day Free Trial													-	-	-	93.32	11,515.75

Competitive Comparison of Freeline Therapeutics Holdings's Days Sales Outstanding

For the Biotechnology subindustry, Freeline Therapeutics Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Freeline Therapeutics Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Freeline Therapeutics Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Freeline Therapeutics Holdings's Days Sales Outstanding falls into.

Freeline Therapeutics Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Freeline Therapeutics Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2022 is calculated as

	Days Sales Outstanding (A: Dec. 2022 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2021 )	+	Accounts Receivable (A: Dec. 2022 ))	/	count )	/	Revenue (A: Dec. 2022 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

Freeline Therapeutics Holdings's Days Sales Outstanding for the quarter that ended in Sep. 2023 is calculated as:

	Days Sales Outstanding (Q: Sep. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Sep. 2023 ))	/	count )	/	Revenue (A: Sep. 2023 )	*	Days in Period
=	( (0.631	+	0)	/	1 )	/	0.005	*	365 / 4
=	0.631					/	0.005	*	365 / 4
=	11,515.75

Freeline Therapeutics Holdings (NAS:FRLN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Freeline Therapeutics Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Freeline Therapeutics Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Freeline Therapeutics Holdings (Freeline Therapeutics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Freeline Therapeutics Holdings PLC (NAS:FRLN) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gunnels Wood Road, Sycamore House, Stevenage, Hertfordshire, GBR, SG1 2BP

Website

https://www.freeline.life

Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from inherited systemic debilitating diseases. Its lead product candidates are FLT180a for the treatment of hemophilia B, FLT190 for the treatment of Fabry disease and FLT201 for the treatment of Gaucher disease Type 1.